Santasa Fertility

Santasa Fertility (officially Santasa Fertility Private Limited, also known as Santasa IVF & Endosurgery Institute) is a pioneering healthcare organization and fertility clinic chain based in Karnataka, India. Established in 2008 in Hassan and expanded to Mysuru in 2014 under the leadership of Dr. Sowmya Dinesh, the institute specializes in advanced reproductive medicine, minimally invasive gynecological endoscopic surgeries, and holistic women's healthcare. Santasa is notable for integrating cutting-edge technologies such as AI-powered andrology and embryology, laser-assisted blastocyst hatching, and advanced regenerative therapies including stem cell-based treatments, platelet-rich plasma (PRP), and bone marrow aspirate concentrate (BMAC). The organization is also recognized for achieving a world-first therapy using intra-amniotic platelet-rich fibrin (PRF) and plasma to seal spontaneous pre-viable amniotic fluid leaks (PVPROM). With an ethical, patient-centered 'Natural Fertility First' philosophy, Santasa prioritizes natural conception and minimally invasive surgeries before proceeding to IVF.